Related parties

3 Months Ended

Nov. 30, 2021

The Company has a long-term pharmaceutical distribution agreement with AmerisourceBergen pursuant to which the Company sources branded and generic pharmaceutical products from AmerisourceBergen principally for its U.S. operations. Additionally, AmerisourceBergen receives sourcing services for generic pharmaceutical products.

Related party transactions with AmerisourceBergen (in millions):


	Three months ended November 30,
	2021		2020
Purchases, net	$	15,791	$	15,441


	November 30, 2021		August 31, 2021
Trade accounts payable, net	$	6,909	$	6,589

See Note 2 Discontinued operations for further information.